Retreating crude oil prices weighed the markets down to a lower open with the Dow losing 19 points to 20,723. Nasdaq fell 14 points to 5,851.
On the upside
Microbes Medical (Nasdaq: MBOT) received a patent for a device that prevents shunt stenosis.
Garmin (Nasdaq: GRMN) reported higher fourth quarter earnings that topped analyst estimates.
Internap (Nasdaq: INAP) raised $43 million through a private placement.
On the downside
An independent data monitoring committee recommended that Argos Therapeutics (Nasdaq: ARGS) discontinue its Phase 3 ADAPT clinical trial of rocapuldencel-T for futility.
Profit taking weighed down shares of Eyegate Pharmaceuticals (Nasdaq: EYEG).
Parker Drilling (NYSE: PKD) priced its public offering of 12 million common shares at the discounted price of $2.10 per share.
The broader S&P 500 index slipped 4 points to 2,360. Bitcoin rose $4 to $1,110.